Search results
Americans With HIV Are Living Longer. Federal Spending Isn’t Keeping Up.
Arizona Mirror via Yahoo News· 5 days agoMore than half of the people living with HIV in the U.S. are older than 50, challenging medical...
Americans with HIV are living longer. Federal spending isn’t keeping up.
Louisiana Illuminator via Yahoo News· 6 days agoDECATUR, Ga. — Malcolm Reid recently marked the anniversary of his HIV diagnosis on Facebook....
Gilead's HIV prevention trial shows promise with zero infections By Investing.com
Investing.com· 3 days ago(NASDAQ:GILD) has reported that its Phase 3 trial of an injectable HIV prevention drug, lenacapavir,...
Health Department selects organization for HIV case management in Lewis, Thurston, Mason and Pierce...
The Chronicle, Centralia, Wash. via Yahoo News· 1 day agoOn Thursday, the DOH announced that CCAP and AHF would provide case management services in Lewis, Mason, Pierce...
Forty years ago, AIDS was a death sentence. Not today, but HIV is still a health threat
Gannett via AOL· 4 days agoHIV-AIDS treatment exists in the U.S. In 2022, about 39 million people globally were living with HIV...
Gilead Flashes Bullish Sign After HIV Drug Proves 100% Effective
Investor's Business Daily· 3 days agoThe news is a boon for Gilead Sciences (GILD), which already sells its HIV drugs Descovy and Truvada...
Gilead’s Twice-Yearly Shot Prevents HIV. Where the Stock Is Headed.
Barrons.com· 3 days agoGilead said there were 39 HIV cases among the 2,136 women who took Descovy and 16 among the 1,068...
Gilead Flashes A Bullish Sign After HIV Drug Proves 100% Effective
Investor's Business Daily· 3 days agoThe news is a boon for Gilead Sciences, which already sells its HIV drugs Descovy and Truvada as...
FDOH hosting several HIV testing events in Orange County
WKMG ClickOrlando· 2 days agoOn Saturday, FDOH will be offering free HIV testing at two locations. One of them is at the Mexican...
Gilead Shot Prevents All HIV Cases in Trial of African Women
Bloomberg via Yahoo Finance· 3 days ago(Bloomberg) -- Gilead Sciences Inc.’s experimental twice-yearly shot prevented 100% of HIV cases in...